Dr Ann Bowron
Consultant Clinical Scientist (Paediatric & Metabolic Biochemistry) Blood Sciences
Qualifications: BSc, MSc, PhD, FRCPath
Office Location: Royal Victoria Infirmary
Ann started her career at the Institute of Child Health in London where she first became interested in inborn errors of metabolism. She trained as a Clinical Scientist at Bristol Royal Infirmary then went on to specialise in paediatric and metabolic biochemistry before moving to Newcastle Hospitals where she leads the metabolic laboratory service, working closely with the North East regional adult and paediatric metabolic teams.
Appointments:
Secretary, UK Metabolic Biochemistry Network (MetBioNet)
Scientific representative on the British Inherited Metabolic Diseases Group committee
Publications:
McNeillis R, Greystoke A, Walton J, Bacon C, Keun H, Siskos A, Petrides G, Leech N, Jenkinson F, Bowron A, Halford S, Plummer R.
Br J Cancer. 2020 Apr;122(8): 1141-1145.
Ketoacidosis in Duchenne muscular dystrophy: A report on 4 cases.
Doris TE, Bowron A, Armstrong A, Messer B.
Neuromuscul Disord. 2018 Aug;28(8):665-670.
Cardiolipin fingerprinting of leukocytes by MALDI-TOF/MS as screening tool for Barth syndrome.
Angelini R, Lobasso S, Gorgoglione R, Bowron A, Steward CG, Corcelli A.
Journal of Lipid Research 2015; 56: 1787-1794.
Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype.
Bowron A, Honeychurch J, Williams M, Tsai-Goodman B, Clayton N, Jones L, Shortland GJ, Qureshi SA, Heales SJ, Steward CG.
Journal of Inherited Metabolic Disease 2015; 38: 279-286
Barth syndrome: an under-diagnosed multisystem disease.
Clarke S, Bowron A, Steward CG et al.
Orphanet Journal of Rare Diseases 2013; 8: 23-40
Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis.
Bowron A, Frost R, Powers VEC, Thomas PH, Heales SJR, Steward CG.
Journal of Inherited Metabolic Disease 2013; 36: 741-6